 | • レポートコード：MRC2-11QY11090 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオプロテーゼのグローバル市場について調査・分析したレポートです。種類別（同種移植、異種移植）市場規模、用途別（心臓血管、形成外科、創傷治癒）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオプロテーゼの競争状況、市場シェア ・世界のバイオプロテーゼ市場：種類別市場規模 2015年-2020年（同種移植、異種移植） ・世界のバイオプロテーゼ市場：種類別市場規模予測 2021年-2026年（同種移植、異種移植） ・世界のバイオプロテーゼ市場：用途別市場規模 2015年-2020年（心臓血管、形成外科、創傷治癒） ・世界のバイオプロテーゼ市場：用途別市場規模予測 2021年-2026年（心臓血管、形成外科、創傷治癒） ・北米のバイオプロテーゼ市場分析：米国、カナダ ・ヨーロッパのバイオプロテーゼ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオプロテーゼ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオプロテーゼ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオプロテーゼ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：LeMaitre Vascular, Inc.、Braile Biomedica, Inc.、Labcor Laboratorios Ltd.、Maquet Metinge Group、Medtronic Plc.、Aortech International Plc.、CryoLife, Inc.、Sorin Group、Humacyte, Inc.、Ethicon, Inc.、Life Cell Corporation、Organogenesis, Inc.、Abbott、Edwards Lifesciences Corporation、JenaValve Technology GmbH ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bioprosthetics are the material obtained from human or other species for medical implantations. Bioprostheses has shown significant advances from past few years, as their basic characteristic, they become degraded until their complete elimination in the host body. Bioprosthesis will gradually degrade in the recipient will determine the formation of a neotissue in its place, which will completely replace the biomaterial in the long term. Ideally , the bioprosthetics are to achieve not only the repair of the damaged zone but also the regeneration of an adequately organized tissue that will promote angiogenesis and even recruit growth factors acquiring characteristics similar to those of healthy tissue.
In 2017, Europe captured a sizeable share of the regional bioprosthetics vertical with a share of near 40.0%. The presence of clearly-defined reimbursement models, prominent industry players, and the large patient volume present in this region are responsible for the large share. Moreover, the formulated, stringent regulatory policies increasingly ensuring patient safety and maintaining high treatment efficacy standards are anticipated to drive the demand for these devices in this region.
Market Analysis and Insights: Global Bioprosthetics Market
The global Bioprosthetics market size is projected to reach US$ 3234.4 million by 2026, from US$ 3038.8 million in 2020, at a CAGR of 6.0%% during 2021-2026.
Global Bioprosthetics Scope and Market Size
Bioprosthetics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bioprosthetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
LeMaitre Vascular, Inc.
Braile Biomedica, Inc.
Labcor Laboratorios Ltd.
Maquet Metinge Group
Medtronic Plc.
Aortech International Plc.
CryoLife, Inc.
Sorin Group
Humacyte, Inc.
Ethicon, Inc.
Life Cell Corporation
Organogenesis, Inc.
Abbott
Edwards Lifesciences Corporation
JenaValve Technology GmbH
Market segment by Type, the product can be split into
Allograft
Xenograft
Market segment by Application, split into
Cardiovascular
Plastic Surgery
Wound Healing
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bioprosthetics Revenue
1.4 Market by Type
1.4.1 Global Bioprosthetics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Allograft
1.4.3 Xenograft
1.5 Market by Application
1.5.1 Global Bioprosthetics Market Share by Application: 2020 VS 2026
1.5.2 Cardiovascular
1.5.3 Plastic Surgery
1.5.4 Wound Healing
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bioprosthetics Market Perspective (2015-2026)
2.2 Global Bioprosthetics Growth Trends by Regions
2.2.1 Bioprosthetics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bioprosthetics Historic Market Share by Regions (2015-2020)
2.2.3 Bioprosthetics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bioprosthetics Market Growth Strategy
2.3.6 Primary Interviews with Key Bioprosthetics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bioprosthetics Players by Market Size
3.1.1 Global Top Bioprosthetics Players by Revenue (2015-2020)
3.1.2 Global Bioprosthetics Revenue Market Share by Players (2015-2020)
3.1.3 Global Bioprosthetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bioprosthetics Market Concentration Ratio
3.2.1 Global Bioprosthetics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bioprosthetics Revenue in 2019
3.3 Bioprosthetics Key Players Head office and Area Served
3.4 Key Players Bioprosthetics Product Solution and Service
3.5 Date of Enter into Bioprosthetics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bioprosthetics Historic Market Size by Type (2015-2020)
4.2 Global Bioprosthetics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bioprosthetics Market Size by Application (2015-2020)
5.2 Global Bioprosthetics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bioprosthetics Market Size (2015-2020)
6.2 Bioprosthetics Key Players in North America (2019-2020)
6.3 North America Bioprosthetics Market Size by Type (2015-2020)
6.4 North America Bioprosthetics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bioprosthetics Market Size (2015-2020)
7.2 Bioprosthetics Key Players in Europe (2019-2020)
7.3 Europe Bioprosthetics Market Size by Type (2015-2020)
7.4 Europe Bioprosthetics Market Size by Application (2015-2020)
8 China
8.1 China Bioprosthetics Market Size (2015-2020)
8.2 Bioprosthetics Key Players in China (2019-2020)
8.3 China Bioprosthetics Market Size by Type (2015-2020)
8.4 China Bioprosthetics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bioprosthetics Market Size (2015-2020)
9.2 Bioprosthetics Key Players in Japan (2019-2020)
9.3 Japan Bioprosthetics Market Size by Type (2015-2020)
9.4 Japan Bioprosthetics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bioprosthetics Market Size (2015-2020)
10.2 Bioprosthetics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bioprosthetics Market Size by Type (2015-2020)
10.4 Southeast Asia Bioprosthetics Market Size by Application (2015-2020)
11 India
11.1 India Bioprosthetics Market Size (2015-2020)
11.2 Bioprosthetics Key Players in India (2019-2020)
11.3 India Bioprosthetics Market Size by Type (2015-2020)
11.4 India Bioprosthetics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bioprosthetics Market Size (2015-2020)
12.2 Bioprosthetics Key Players in Central & South America (2019-2020)
12.3 Central & South America Bioprosthetics Market Size by Type (2015-2020)
12.4 Central & South America Bioprosthetics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 LeMaitre Vascular, Inc.
13.1.1 LeMaitre Vascular, Inc. Company Details
13.1.2 LeMaitre Vascular, Inc. Business Overview
13.1.3 LeMaitre Vascular, Inc. Bioprosthetics Introduction
13.1.4 LeMaitre Vascular, Inc. Revenue in Bioprosthetics Business (2015-2020))
13.1.5 LeMaitre Vascular, Inc. Recent Development
13.2 Braile Biomedica, Inc.
13.2.1 Braile Biomedica, Inc. Company Details
13.2.2 Braile Biomedica, Inc. Business Overview
13.2.3 Braile Biomedica, Inc. Bioprosthetics Introduction
13.2.4 Braile Biomedica, Inc. Revenue in Bioprosthetics Business (2015-2020)
13.2.5 Braile Biomedica, Inc. Recent Development
13.3 Labcor Laboratorios Ltd.
13.3.1 Labcor Laboratorios Ltd. Company Details
13.3.2 Labcor Laboratorios Ltd. Business Overview
13.3.3 Labcor Laboratorios Ltd. Bioprosthetics Introduction
13.3.4 Labcor Laboratorios Ltd. Revenue in Bioprosthetics Business (2015-2020)
13.3.5 Labcor Laboratorios Ltd. Recent Development
13.4 Maquet Metinge Group
13.4.1 Maquet Metinge Group Company Details
13.4.2 Maquet Metinge Group Business Overview
13.4.3 Maquet Metinge Group Bioprosthetics Introduction
13.4.4 Maquet Metinge Group Revenue in Bioprosthetics Business (2015-2020)
13.4.5 Maquet Metinge Group Recent Development
13.5 Medtronic Plc.
13.5.1 Medtronic Plc. Company Details
13.5.2 Medtronic Plc. Business Overview
13.5.3 Medtronic Plc. Bioprosthetics Introduction
13.5.4 Medtronic Plc. Revenue in Bioprosthetics Business (2015-2020)
13.5.5 Medtronic Plc. Recent Development
13.6 Aortech International Plc.
13.6.1 Aortech International Plc. Company Details
13.6.2 Aortech International Plc. Business Overview
13.6.3 Aortech International Plc. Bioprosthetics Introduction
13.6.4 Aortech International Plc. Revenue in Bioprosthetics Business (2015-2020)
13.6.5 Aortech International Plc. Recent Development
13.7 CryoLife, Inc.
13.7.1 CryoLife, Inc. Company Details
13.7.2 CryoLife, Inc. Business Overview
13.7.3 CryoLife, Inc. Bioprosthetics Introduction
13.7.4 CryoLife, Inc. Revenue in Bioprosthetics Business (2015-2020)
13.7.5 CryoLife, Inc. Recent Development
13.8 Sorin Group
13.8.1 Sorin Group Company Details
13.8.2 Sorin Group Business Overview
13.8.3 Sorin Group Bioprosthetics Introduction
13.8.4 Sorin Group Revenue in Bioprosthetics Business (2015-2020)
13.8.5 Sorin Group Recent Development
13.9 Humacyte, Inc.
13.9.1 Humacyte, Inc. Company Details
13.9.2 Humacyte, Inc. Business Overview
13.9.3 Humacyte, Inc. Bioprosthetics Introduction
13.9.4 Humacyte, Inc. Revenue in Bioprosthetics Business (2015-2020)
13.9.5 Humacyte, Inc. Recent Development
13.10 Ethicon, Inc.
13.10.1 Ethicon, Inc. Company Details
13.10.2 Ethicon, Inc. Business Overview
13.10.3 Ethicon, Inc. Bioprosthetics Introduction
13.10.4 Ethicon, Inc. Revenue in Bioprosthetics Business (2015-2020)
13.10.5 Ethicon, Inc. Recent Development
13.11 Life Cell Corporation
10.11.1 Life Cell Corporation Company Details
10.11.2 Life Cell Corporation Business Overview
10.11.3 Life Cell Corporation Bioprosthetics Introduction
10.11.4 Life Cell Corporation Revenue in Bioprosthetics Business (2015-2020)
10.11.5 Life Cell Corporation Recent Development
13.12 Organogenesis, Inc.
10.12.1 Organogenesis, Inc. Company Details
10.12.2 Organogenesis, Inc. Business Overview
10.12.3 Organogenesis, Inc. Bioprosthetics Introduction
10.12.4 Organogenesis, Inc. Revenue in Bioprosthetics Business (2015-2020)
10.12.5 Organogenesis, Inc. Recent Development
13.13 Abbott
10.13.1 Abbott Company Details
10.13.2 Abbott Business Overview
10.13.3 Abbott Bioprosthetics Introduction
10.13.4 Abbott Revenue in Bioprosthetics Business (2015-2020)
10.13.5 Abbott Recent Development
13.14 Edwards Lifesciences Corporation
10.14.1 Edwards Lifesciences Corporation Company Details
10.14.2 Edwards Lifesciences Corporation Business Overview
10.14.3 Edwards Lifesciences Corporation Bioprosthetics Introduction
10.14.4 Edwards Lifesciences Corporation Revenue in Bioprosthetics Business (2015-2020)
10.14.5 Edwards Lifesciences Corporation Recent Development
13.15 JenaValve Technology GmbH
10.15.1 JenaValve Technology GmbH Company Details
10.15.2 JenaValve Technology GmbH Business Overview
10.15.3 JenaValve Technology GmbH Bioprosthetics Introduction
10.15.4 JenaValve Technology GmbH Revenue in Bioprosthetics Business (2015-2020)
10.15.5 JenaValve Technology GmbH Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bioprosthetics Key Market Segments
Table 2. Key Players Covered: Ranking by Bioprosthetics Revenue
Table 3. Ranking of Global Top Bioprosthetics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bioprosthetics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Allograft
Table 6. Key Players of Xenograft
Table 7. Global Bioprosthetics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Bioprosthetics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Bioprosthetics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Bioprosthetics Market Share by Regions (2015-2020)
Table 11. Global Bioprosthetics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Bioprosthetics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Bioprosthetics Market Growth Strategy
Table 17. Main Points Interviewed from Key Bioprosthetics Players
Table 18. Global Bioprosthetics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Bioprosthetics Market Share by Players (2015-2020)
Table 20. Global Top Bioprosthetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioprosthetics as of 2019)
Table 21. Global Bioprosthetics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bioprosthetics Product Solution and Service
Table 24. Date of Enter into Bioprosthetics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Bioprosthetics Market Size Share by Type (2015-2020)
Table 28. Global Bioprosthetics Revenue Market Share by Type (2021-2026)
Table 29. Global Bioprosthetics Market Size Share by Application (2015-2020)
Table 30. Global Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Bioprosthetics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Bioprosthetics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Bioprosthetics Market Share (2019-2020)
Table 34. North America Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Bioprosthetics Market Share by Type (2015-2020)
Table 36. North America Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Bioprosthetics Market Share by Application (2015-2020)
Table 38. Europe Key Players Bioprosthetics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Bioprosthetics Market Share (2019-2020)
Table 40. Europe Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Bioprosthetics Market Share by Type (2015-2020)
Table 42. Europe Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Bioprosthetics Market Share by Application (2015-2020)
Table 44. China Key Players Bioprosthetics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Bioprosthetics Market Share (2019-2020)
Table 46. China Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 47. China Bioprosthetics Market Share by Type (2015-2020)
Table 48. China Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 49. China Bioprosthetics Market Share by Application (2015-2020)
Table 50. Japan Key Players Bioprosthetics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Bioprosthetics Market Share (2019-2020)
Table 52. Japan Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Bioprosthetics Market Share by Type (2015-2020)
Table 54. Japan Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Bioprosthetics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Bioprosthetics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Bioprosthetics Market Share (2019-2020)
Table 58. Southeast Asia Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Bioprosthetics Market Share by Type (2015-2020)
Table 60. Southeast Asia Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Bioprosthetics Market Share by Application (2015-2020)
Table 62. India Key Players Bioprosthetics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Bioprosthetics Market Share (2019-2020)
Table 64. India Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 65. India Bioprosthetics Market Share by Type (2015-2020)
Table 66. India Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 67. India Bioprosthetics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Bioprosthetics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Bioprosthetics Market Share (2019-2020)
Table 70. Central & South America Bioprosthetics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Bioprosthetics Market Share by Type (2015-2020)
Table 72. Central & South America Bioprosthetics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Bioprosthetics Market Share by Application (2015-2020)
Table 74. LeMaitre Vascular, Inc. Company Details
Table 75. LeMaitre Vascular, Inc. Business Overview
Table 76. LeMaitre Vascular, Inc. Product
Table 77. LeMaitre Vascular, Inc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 78. LeMaitre Vascular, Inc. Recent Development
Table 79. Braile Biomedica, Inc. Company Details
Table 80. Braile Biomedica, Inc. Business Overview
Table 81. Braile Biomedica, Inc. Product
Table 82. Braile Biomedica, Inc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 83. Braile Biomedica, Inc. Recent Development
Table 84. Labcor Laboratorios Ltd. Company Details
Table 85. Labcor Laboratorios Ltd. Business Overview
Table 86. Labcor Laboratorios Ltd. Product
Table 87. Labcor Laboratorios Ltd. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 88. Labcor Laboratorios Ltd. Recent Development
Table 89. Maquet Metinge Group Company Details
Table 90. Maquet Metinge Group Business Overview
Table 91. Maquet Metinge Group Product
Table 92. Maquet Metinge Group Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 93. Maquet Metinge Group Recent Development
Table 94. Medtronic Plc. Company Details
Table 95. Medtronic Plc. Business Overview
Table 96. Medtronic Plc. Product
Table 97. Medtronic Plc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 98. Medtronic Plc. Recent Development
Table 99. Aortech International Plc. Company Details
Table 100. Aortech International Plc. Business Overview
Table 101. Aortech International Plc. Product
Table 102. Aortech International Plc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 103. Aortech International Plc. Recent Development
Table 104. CryoLife, Inc. Company Details
Table 105. CryoLife, Inc. Business Overview
Table 106. CryoLife, Inc. Product
Table 107. CryoLife, Inc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 108. CryoLife, Inc. Recent Development
Table 109. Sorin Group Business Overview
Table 110. Sorin Group Product
Table 111. Sorin Group Company Details
Table 112. Sorin Group Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 113. Sorin Group Recent Development
Table 114. Humacyte, Inc. Company Details
Table 115. Humacyte, Inc. Business Overview
Table 116. Humacyte, Inc. Product
Table 117. Humacyte, Inc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 118. Humacyte, Inc. Recent Development
Table 119. Ethicon, Inc. Company Details
Table 120. Ethicon, Inc. Business Overview
Table 121. Ethicon, Inc. Product
Table 122. Ethicon, Inc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 123. Ethicon, Inc. Recent Development
Table 124. Life Cell Corporation Company Details
Table 125. Life Cell Corporation Business Overview
Table 126. Life Cell Corporation Product
Table 127. Life Cell Corporation Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 128. Life Cell Corporation Recent Development
Table 129. Organogenesis, Inc. Company Details
Table 130. Organogenesis, Inc. Business Overview
Table 131. Organogenesis, Inc. Product
Table 132. Organogenesis, Inc. Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 133. Organogenesis, Inc. Recent Development
Table 134. Abbott Company Details
Table 135. Abbott Business Overview
Table 136. Abbott Product
Table 137. Abbott Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 138. Abbott Recent Development
Table 139. Edwards Lifesciences Corporation Company Details
Table 140. Edwards Lifesciences Corporation Business Overview
Table 141. Edwards Lifesciences Corporation Product
Table 142. Edwards Lifesciences Corporation Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 143. Edwards Lifesciences Corporation Recent Development
Table 144. JenaValve Technology GmbH Company Details
Table 145. JenaValve Technology GmbH Business Overview
Table 146. JenaValve Technology GmbH Product
Table 147. JenaValve Technology GmbH Revenue in Bioprosthetics Business (2015-2020) (Million US$)
Table 148. JenaValve Technology GmbH Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bioprosthetics Market Share by Type: 2020 VS 2026
Figure 2. Allograft Features
Figure 3. Xenograft Features
Figure 4. Global Bioprosthetics Market Share by Application: 2020 VS 2026
Figure 5. Cardiovascular Case Studies
Figure 6. Plastic Surgery Case Studies
Figure 7. Wound Healing Case Studies
Figure 8. Bioprosthetics Report Years Considered
Figure 9. Global Bioprosthetics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Bioprosthetics Market Share by Regions: 2020 VS 2026
Figure 11. Global Bioprosthetics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Bioprosthetics Market Share by Players in 2019
Figure 14. Global Top Bioprosthetics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioprosthetics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Bioprosthetics Revenue in 2019
Figure 16. North America Bioprosthetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Bioprosthetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Bioprosthetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Bioprosthetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Bioprosthetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Bioprosthetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Bioprosthetics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
創傷治癒の世界市場（～2026年） The developments and innovations in the wound care products and the rising investments for the research of wound care are estimated to accelerate the growth of the market in the next few years. In addition to this, the rise in the number of trauma injuries and road accidents and the rising popularit…- 成形外科・外皮系処置の世界市場（～2026年） Plastic surgery is a surgical specialty involving the restoration, reconstruction, or alteration of the human body. Plastic surgery can be divided into two categories. The first is reconstructive surgery which includes craniofacial surgery, hand surgery, microsurgery, and the treatment of burns. The…
- 成形外科の世界市場（～2026年） Plastic surgery is a surgical specialty involving the restoration, reconstruction or alteration of the human body. Plastic surgery can be divided into two categories. The first is reconstructive surgery which includes craniofacial surgery, hand surgery, microsurgery and the treatment of burns. The o…
- 患者由来異種移植/PDXモデルの世界市場（～2026年） Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment eval…
- 心血管インプラントの世界市場（～2026年） Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart fai…